Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,683
  • Shares Outstanding, K 79,724
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,640 K
  • 60-Month Beta 0.44
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.06
Trade SLNO with:

Options Overview

Details
  • Implied Volatility 122.94%
  • Historical Volatility 62.96%
  • IV Percentile 11%
  • IV Rank 5.38%
  • IV High 613.04% on 05/29/20
  • IV Low 95.05% on 01/20/21
  • Put/Call Vol Ratio 0.01
  • Today's Volume 478
  • Volume Avg (30-Day) 547
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 15,728
  • Open Int (30-Day) 7,925

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +69.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1101 +3.59%
on 04/12/21
1.7200 -33.14%
on 03/17/21
-0.4900 (-29.88%)
since 03/16/21
3-Month
1.1101 +3.59%
on 04/12/21
3.3599 -65.77%
on 02/09/21
-0.9400 (-44.98%)
since 01/15/21
52-Week
1.1101 +3.59%
on 04/12/21
4.3900 -73.80%
on 05/21/20
-1.9400 (-62.78%)
since 04/16/20

Most Recent Stories

More News
Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D.,...

SLNO : 1.1500 (-2.54%)
Soleno Therapeutics (SLNO) Enters Oversold Territory

Soleno Therapeutics (SLNO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

SLNO : 1.1500 (-2.54%)
Pacira (PCRX) Gets FDA Nod for Exparel in Pediatric Patients

The FDA approves Pacira's (PCRX) Exparel for use in patients aged six years and older for single-dose infiltration to produce postsurgical local analgesia.

PCRX : 63.07 (-4.93%)
CANF : 2.09 (-4.13%)
OPHLF : 25.0500 (unch)
SLNO : 1.1500 (-2.54%)
Catalyst (CPRX) Beats on Q4 Earnings, Revenues Rise Y/Y

Catalyst's (CPRX) earnings and revenues beat estimates in the fourth quarter of 2020.

ZTS : 167.63 (+1.32%)
CPRX : 4.44 (-0.67%)
CTLT : 110.60 (-0.35%)
SLNO : 1.1500 (-2.54%)
Soleno to Participate in the 31st Annual Oppenheimer Healthcare Conference

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D.,...

SLNO : 1.1500 (-2.54%)
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Soleno Therapeutics, Inc. (SLNO) and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 9, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ:SLNO)....

SLNO : 1.1500 (-2.54%)
Soleno Therapeutics (SLNO) Is in Oversold Territory: What's Next?

Soleno Therapeutics (SLNO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock

SLNO : 1.1500 (-2.54%)
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an update following recent...

SLNO : 1.1500 (-2.54%)
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020 Financial Results

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update and announced...

SLNO : 1.1500 (-2.54%)
Soleno Therapeutics Announces Collaboration with Vanderbilt University to Discover and Develop Next Generation K(ATP) Channel Activators for the Treatment of Rare Diseases

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it has signed a collaboration...

SLNO : 1.1500 (-2.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 1.2462
2nd Resistance Point 1.2149
1st Resistance Point 1.1825
Last Price 1.1500
1st Support Level 1.1188
2nd Support Level 1.0875
3rd Support Level 1.0551

See More

52-Week High 4.3900
Fibonacci 61.8% 3.1371
Fibonacci 50% 2.7501
Fibonacci 38.2% 2.3630
Last Price 1.1500
52-Week Low 1.1101

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar